Dendreon Corp. (DNDN) announced an agreement to settle the securities class action litigation pending against the company, and three current and former executive officers, in the United States District Court for the Western District of Washington.
In the lawsuit, captioned In re Dendreon Corporation Class Action Litigation, Master Docket No. C 11-1291 JLR., an investor, purporting to represent a class consisting of persons who purchased Dendreon common stock between April 29, 2010 and August 3, 2011, sought unspecified damages from Dendreon and three current and former officers of the company for allegedly false or misleading statements concerning the company, its finances, business operations and prospects with a focus on the market launch of PROVENGE and related forecasts concerning physician adoption, and revenue from sales of PROVENGE.
Upon final approval, the settlement will resolve the claims asserted against all defendants. The terms contemplates a settlement payment of $40 million, $38 million of which will be funded by Dendreon's insurers. Dendreon said the company and the individual defendants continue to deny that any statements they made were false or misleading.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.